Literature DB >> 35019711

E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Paloma Hidalgo1, Yasel Garcés2, Eduardo Mundo3, Raúl E López2,3, Luca D Bertzbach1, Thomas Dobner1, Ramón A González3.   

Abstract

The multifunctional adenoviral E1B-55K phosphoprotein is a major regulator of viral replication and plays key roles in virus-mediated cell transformation. While much is known about its function in oncogenic cell transformation, the underlying features and exact mechanisms that implicate E1B-55K in the regulation of viral gene expression are less well understood. Therefore, this work aimed to unravel basic intranuclear principles of E1B-55K-regulated viral mRNA biogenesis using wild-type human adenovirus C5 (HAdV-C5) E1B-55K, a virus mutant with abrogated E1B-55K expression, and a mutant that expresses a phosphomimetic E1B-55K. By subnuclear fractionation, mRNA, DNA, and protein analyses as well as luciferase reporter assays, we show that (i) E1B-55K promotes the efficient release of viral late mRNAs from their site of synthesis in viral replication compartments (RCs) to the surrounding nucleoplasm, (ii) E1B-55K modulates the rate of viral gene transcription and splicing in RCs, (iii) E1B-55K participates in the temporal regulation of viral gene expression, (iv) E1B-55K can enhance or repress the expression of viral early and late promoters, and (v) the phosphorylation of E1B-55K regulates the temporal effect of the protein on each of these activities. Together, these data demonstrate that E1B-55K is a phosphorylation-dependent transcriptional and posttranscriptional regulator of viral genes during HAdV-C5 infection. IMPORTANCE Human adenoviruses are useful models to study basic aspects of gene expression and splicing. Moreover, they are one of the most commonly used viral vectors for clinical applications. However, key aspects of the activities of essential viral proteins that are commonly modified in adenoviral vectors have not been fully described. A prominent example is the multifunctional adenoviral oncoprotein E1B-55K that is known to promote efficient viral genome replication and expression while simultaneously repressing host gene expression and antiviral host responses. Our study combined different quantitative methods to study how E1B-55K promotes viral mRNA biogenesis. The data presented here propose a novel role for E1B-55K as a phosphorylation-dependent transcriptional and posttranscriptional regulator of viral genes.

Entities:  

Keywords:  E1B-55K; dual transcriptional regulator; human adenovirus; phosphorylation; splicing; transcription; viral mRNA synthesis; viral replication compartments

Mesh:

Substances:

Year:  2022        PMID: 35019711      PMCID: PMC8906433          DOI: 10.1128/jvi.02062-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  94 in total

Review 1.  Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

Authors:  W S Wold; K Doronin; K Toth; M Kuppuswamy; D L Lichtenstein; A E Tollefson
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

2.  Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo.

Authors:  Almudena Pardo-Mateos; C S H Young
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

3.  The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Authors:  Humayra Ali; Gary LeRoy; Gemma Bridge; S J Flint
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

4.  Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.

Authors:  Ramon Gonzalez; Wenying Huang; Renee Finnen; Courtney Bragg; S J Flint
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  The product of the adenovirus intermediate gene IX is a transcriptional activator.

Authors:  P Lutz; M Rosa-Calatrava; C Kedinger
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.

Authors:  M Kornuc; S Kliewer; J Garcia; D Harrich; C Li; R Gaynor
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K.

Authors:  Jordan Wright; Zeenah Atwan; Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

8.  Multiplexed gene control reveals rapid mRNA turnover.

Authors:  Antoine Baudrimont; Sylvia Voegeli; Eduardo Calero Viloria; Fabian Stritt; Marine Lenon; Takeo Wada; Vincent Jaquet; Attila Becskei
Journal:  Sci Adv       Date:  2017-07-12       Impact factor: 14.136

9.  The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53.

Authors:  Jordan Wright; Keith N Leppard
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

10.  SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection.

Authors:  Sabrina Schreiner; Sarah Kinkley; Carolin Bürck; Andreas Mund; Peter Wimmer; Tobias Schubert; Peter Groitl; Hans Will; Thomas Dobner
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

View more
  2 in total

1.  Adipocyte commitment of 3T3-L1 cells is required to support human adenovirus 36 productive replication concurrent with altered lipid and glucose metabolism.

Authors:  Verónica Márquez; Grisel Ballesteros; Thomas Dobner; Ramón A González
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

2.  Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.

Authors:  Marie Fiedler; Wing-Hang Ip; Helga Hofmann-Sieber; Britta Wilkens; Francis K Nkrumah; Wenli Zhang; Anja Ehrhardt; Luca D Bertzbach; Thomas Dobner
Journal:  Viruses       Date:  2022-02-24       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.